[1]张晓静,季德江,冯亚宏,等.健脾益肾化浊方联合生活方式干预对肥胖型多囊卵巢综合征患者胰岛素抵抗及糖脂代谢的影响[J].陕西中医,2025,46(5):624-629.[doi:DOI:10.3969/j.issn.1000-7369.2025.05.010]
　ZHANG Xiaojing,JI Dejiang,FENG Yahong,et al.Effects of Jianpi Yishen Huazhuo prescription combined with lifestyle on insulin resistance and glucose and lipid metabolism in obese polycystic ovary syndrome[J].,2025,46(5):624-629.[doi:DOI:10.3969/j.issn.1000-7369.2025.05.010]
点击复制

健脾益肾化浊方联合生活方式干预对肥胖型多囊卵巢综合征患者胰岛素抵抗及糖脂代谢的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
46
期数:
2025年5期
页码:
624-629
栏目:
临床研究
出版日期:
2025-05-05

文章信息/Info

Title:
Effects of Jianpi Yishen Huazhuo prescription combined with lifestyle on insulin resistance and glucose and lipid metabolism in obese polycystic ovary syndrome
作者:
张晓静1; 季德江1; 冯亚宏1; 杜翠忠1; 马梅香2; 李玲义2
(1.宁夏回族自治区中医医院暨中医研究院,宁夏 银川 750021; 2.甘肃中医药大学,甘肃 兰州 730030)
Author(s):
ZHANG Xiaojing1 ; JI Dejiang1; FENG Yahong1; DU Cuizhong1; MA Meixiang2; LI Lingyi2
(1.Ningxia Hui Autonomous Region Oriental Medicine Hospital and Institute of Oriental Medicine,Yinchuan 750021,China; 2.Gansu University of Chinese Medicine,Lanzhou 730030,China)
关键词:
多囊卵巢综合征;  肥胖;  胰岛素抵抗;  健脾益肾化浊方;  生活方式;  糖脂代谢
Keywords:
Polycystic ovary syndrome;  Obesity;  Insulin resistance;  Jianpi Yishen Huazhuo prescription;  The way of life;  Glycolipid metabolism
分类号:
R 711.75
DOI:
DOI:10.3969/j.issn.1000-7369.2025.05.010
文献标志码:
A
摘要:
目的:探讨健脾益肾化浊方联合生活方式对肥胖型多囊卵巢综合征(PCOS)胰岛素抵抗及糖脂代谢的影响。方法:选取88例肥胖型PCOS患者,对照组及试验组各44例。两组均由专业的营养师给予生活方式干预指导,对照组给予二甲双胍肠溶片,试验组给予健脾益肾化浊方,共治疗3个月经周期。观察两组患者治疗前后体重指数(BMI)变化情况; 生化分析仪测定空腹葡萄糖(FPG)、胰岛素(INS)、胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)水平; ELISA法测定白细胞介素6(IL-6)、肿瘤坏死因子(TNF-α)、胰高血糖素(GC)、抵抗素(Resistin)、性激素水平[促卵泡生成素(FSH)、促黄体生成素(LH)、垂体泌乳素(PRL)、雌二醇(E2)、孕酮(P)、睾酮(T)、硫酸脱氢表雄酮(DHES)]; Western blot检测脂联素(ADPN)、瘦素(Leptin)、脂肪酸结合蛋白(FABP1)、脂肪酸转运蛋白(FATP2)、脂肪酸氧化酶(FAO)指标情况。结果:治疗后,两组患者BMI均显著下降,试验组在LDL-C和HDL-C水平的改善显著优于对照组(P<0.01),而两组在FPG、INS、TC和TG方面比较差异无统计学意义(P>0.05); 对照组的T和E2的水平显著降低,试验组的T和DHES显著下降; 试验组IL-6、TNF-α和Resistin有轻微的下降趋势(均P<0.05); 健脾益肾化浊方治疗后的PCOS患者体内的Leptin和FATP2的蛋白表达极显著下调(P<0.001),ADPN、FAO表达极显著上调(P<0.001,P<0.01)。结论:健脾益肾化浊方联合生活方式干预能够升高ADPN及FAO蛋白表达,下调Leptin和FATP2的蛋白表达,调节激素水平、改善糖脂代谢,提高胰岛素敏感性,从而发挥治疗作用。
Abstract:
Objective:To explore the effects of Jianpi Yishen Huazhuo prescription combined with lifestyle on insulin resistance and glucose and lipid metabolism in obese polycystic ovary syndrome(PCOS).Methods:A total of 88 obese PCOS patients,44 in control group and 44 in test group,were selected.Both groups were given lifestyle intervention guidance by professional dietitians,the control group was given metformin enteric-coated tablets,and the test group was given Jianpi Yishen Huazhuo prescription,a total of 3 menstrual cycles.The changes of body mass index(BMI)before and after treatment were observed.The levels of fasting glucose(FPG),insulin(INS),cholesterol(TC),triglyceride(TG),high density lipoprotein cholesterol(HDL-C)and low density lipoprotein cholesterol(LDL-C)were measured by biochemical analyzer.Serum levels of interleukin-6(IL-6),tumor necrosis factor(TNF-α),glucagon(GC),Resistin(Resistin),sex hormones follicle-stimulating hormone(FSH),luteinizing hormone(LH),pituitary prolactin(PRL),estradiol(E2),progesterone(P),testosterone(T),sulfur were measured by ELISA Acid dehydroepiandrosterone(DHES); Western blot detection of adiponectin(ADPN),leptin(leptin),fatty acid binding protein(FABP1),fatty acid transporter protein(FATP2),fatty acid oxidase(FAO)indexes.Results:After treatment,BMI was significantly decreased in both groups,and the improvement of LDL and HDL levels in test group was significantly better than that in control group(P<0.01),but there were no significant differences in fasting blood glucose,fasting insulin,triglyceride and total cholesterol between two groups(P>0.05).The levels of T and E2 in the control group were significantly decreased,and the levels of T and DHES in the experimental group were significantly decreased.In the test group,IL-6,TNF-α and Resistin showed a slight tendency to decline(all P<0.05).The protein expressions of Leptin and FATP2 in PCOS patients treated with Jianpi Yishen Huazhuo prescription were significantly down-regulated(P<0.001),and the expressions of ADPN and FAO were significantly up-regulated(P<0.001,P<0.01).Conclusion:The combination of Jianpi Yishen Huazhuo prescription and lifestyle intervention can increase the protein expression of ADPN and FAO,down-regulate the protein expression of Leptin and FATP2,regulate hormone levels,improve glucose and lipid metabolism,and increase insulin sensitivity,thus playing a therapeutic role.

参考文献/References:

[1] BAHRI KHOMAMI M,TEEDE H J,JOHAM A E,et al.Clinical management of pregnancy in women with polycystic ovary syndrome:An expert opinion[J].Clin Endocrinol,2022,97(2):227-236.
[2] 蒋丽琴.PCOS患者月经模式与性激素、糖脂代谢关系[J].中国计划生育学杂志,2023,31(11):2665-2669.
[3] ZOLTAN K I,ILDIKO K,MELINDA K.Current aspects of polycystic ovary syndrome I:Treatment of hyperandro-genism,insulin resistance and infertility[J].Bulletin Med Sci,2019,92(2):89-104.
[4] 郭影.血清及子宫内膜中鸢尾素水平与多囊卵巢综合征的相关性研究[D].石家庄:河北医科大学,2017.
[5] RUDNICKA E,SUCHTA K,GRYMOWICZ M,et al.Chronic low grade inflammation in pathogenesis of PCOS[J].Int J Mol Sci,2021,22(7):3789.
[6] 冯亚宏,张晓静,杜翠忠.健脾益肾化浊方治疗肥胖型多囊卵巢综合征60例临床观察[J].母婴世界,2021,5(1):100.
[7] 陈苗,杜小利,冯亚宏,等.基于NLRP3炎症通路探讨健脾益肾化浊方对多囊卵巢综合征大鼠卵巢功能的影响[J].中国实验方剂学杂志,2022,28(20):201-211.
[8] 宋颖,李蓉.多囊卵巢综合征中国诊疗指南解读[J].实用妇产科杂志,2018,34(10):737-741.
[9] 中国居民肥胖防治专家共识[J].中国预防医学杂志,2022,23(5):321-339.
[10] 万幸,江玲,杨雅琪,等.加味苍附导痰汤联合耳穴治疗多囊卵巢综合征痰瘀证临床研究[J].陕西中医,2022,43(12):1797-1800.
[11] 王春红,于普光,孙亚群,等.温中补肾方对多囊卵巢综合征改善作用及对雌性生殖干细胞增殖的影响[J].中华中医药杂志,2022,37(6):3564-3568.
[12] 孙红,王志华.多囊卵巢综合征痰湿型50例患者与女性激素及胰岛素抵抗的关系报道[J].世界中医药,2011,6(5):405-406.
[13] 姜晓琳,刘静,张阳,等.苍附导痰汤加二甲双胍联合穴位埋线对肥胖型多囊卵巢综合征不孕症患者免疫功能及肠道菌群的影响[J].临床误诊误治,2020,33(8):51-56.
[14] 林鑫.Periostin对血管紧张素Ⅱ诱导胆固醇逆转运相关因子的影响[D].太原:山西医科大学,2022.
[15] 孙晓彤,丛培玮,吴兆利.基于带脉理论探讨腹型肥胖多囊卵巢综合征辨治思路[J].陕西中医,2022,43(1):93-96.
[16] 张文慧.屈螺酮炔雌醇联合生活方式管理对青春期肥胖型多囊卵巢综合征合并胰岛素抵抗患者的治疗效果[J].慢性病学杂志,2024,25(3):445-447.
[17] 杨珺兰,王泽,邹晓燕,等.PCOS肥胖脂代谢特点及相关基因研究进展[J].现代妇产科进展,2022,31(5):377-379,383.
[18] 张晓静,陈苗,冯亚宏,等.基于Bax/Bcl-2/Caspase-3通路探讨健脾益肾化浊方对多囊卵巢综合征大鼠卵巢功能的改善作用[J].中国现代应用药学,2023,40(20):2891-2896.
[19] 孙博洋,韩世愈.慢性低度炎症与多囊卵巢综合征关系的研究进展[J].中国优生与遗传杂志,2022,30(1):161-164.
[20] ZHUANG Z,PAN X,ZHAO K,et al.The effect of interleukin-6(IL-6),interleukin-11(IL-11),signal transducer and activator of transcription 3(STAT3),and Akt signaling on adipocyte proliferation in a rat model of polycystic ovary syndrome[J].Med Sci Monit,2019,26(25):7218-7227.
[21] POPOVIC M,SARTORIUS G,CHRIST-CRAIN M.Chronic low-grade inflammation in polycystic ovary syndrome:Is there a(patho)-physiological role for interleukin-1[J].Semin Immunopathol,2019,41(4):447-459.
[22] 陈苗,杜小利,冯亚宏,等.基于NLRP3炎症通路探讨健脾益肾化浊方对多囊卵巢综合征大鼠卵巢功能的影响[J].中国实验方剂学杂志,2022,28(20):61-70.
[23] 叶涛.中性粒细胞/淋巴细胞比率预测慢性阻塞性肺疾病并发2型糖尿病的价值:前瞻性队列研究[D].广州:南方医科大学,2019.
[24] 丁芳,周靖,易晓芳.血清瘦素、脂联素、抵抗素与多囊卵巢综合征的相关研究[J].中国临床研究,2019,32(8):1087-1090.
[25] 郭倩愉.脂肪细胞因子A-FABP调控颗粒细胞功能介导多囊卵巢综合征的作用与中药复方FTZ的干预机制研究[D].广州:广东药科大学,2020.

相似文献/References:

[1]欧丽芬,张莹轩,周英.葛根汤合四逆散在多囊卵巢综合征型痤疮中的应用[J].陕西中医,2017,(06):791.
[2]王改梅,李 晶,张 励,等.苍附导痰方联合法地兰对PCOS合并不孕症患者性激素水平 及子宫内膜容受性的影响*[J].陕西中医,2019,(2):201.
　WANG Gaimei,LI Jing,ZHANG Li,et al.Effect of Cangfu Daotan prescription combined with Fadiland on sex hormone level and endometrial receptivity in PCOS patients with infertility[J].,2019,(5):201.
[3]袁社霞.补肾促排方治疗多囊卵巢综合征排卵障碍性不孕临床研究*[J].陕西中医,2019,(1):12.
　YUAN Shexia..Clinical observation on the therapeutic effect of Bushen Cupai recipe on ovulation disorder infertility in polycystic ovary syndrome[J].,2019,(5):12.
[4]高翠霞,宋红湘.补肾调经汤联合温针灸督脉治疗多囊卵巢综合征疗效及对患者内分泌系统和排卵的影响*[J].陕西中医,2019,(1):21.
[5]石小哲,张大伟.温肾健脾汤治疗多囊卵巢综合征及对患者胰岛素抵抗、 激素水平的影响*[J].陕西中医,2019,(5):637.
　SHI Xiaozhe,ZHANG Dawei..Curative effect of Wenshen Jianpi decoction in the treatment of polycystic ovary syndrome and the influence on insulin resistance and hormone levels[J].,2019,(5):637.
[6]马志宾,陈 燕,苏 永.促排卵汤对多囊卵巢综合征患者血清淀粉样蛋白P、脂肪因子 与白介素-18的影响研究*[J].陕西中医,2019,(5):651.
　MA Zhibin,HU Xiaohua,SU Yong ..Effect of Cupailuan decoction combined with life style on serum SAP, Apelin and IL-18 in women with polycystic ovary syndrome[J].,2019,(5):651.
[7]刘彩娜,李佳佳,李林林,等.温针灸督脉联合克罗米芬治疗肾虚血瘀型多囊卵巢综合征不孕临床研究*[J].陕西中医,2019,(6):803.
[8]李海霞,史秀英,王璀瑛,等.益肾化痰方治疗肥胖型多囊卵巢综合征不孕临床研究[J].陕西中医,2019,(7):839.
　LI Haixia,SHI Xiuying,WANG Cuiying,et al.Clinical study of Yishen Huatan decoction in the treatment of obese polycystic ovarian syndrome infertility[J].,2019,(5):839.
[9]冯亚宏,许 昕△.许昕教授治疗多囊卵巢综合征经验探析*[J].陕西中医,2020,(3):374.
[10]巴明玉,娄永强,禄保平△.健脾疏肝降脂方干预非酒精性脂肪肝病肥胖小鼠肝功能、游离脂肪酸机制探讨*[J].陕西中医,2020,(4):434.
　BA Mingyu,LOU Yongqiang,LU Baoping..Effect and mechanism of Jianpi Shugan Jiangzhi recipe on liver function and FFA in NAFLD obese mice[J].,2020,(5):434.
[11]申航旗,何燕南.从“肥胖不孕”探讨肥胖对多囊卵巢综合征的影响[J].陕西中医,2024,(1):84.[doi:DOI:10.3969/j.issn.1000-7369.2024.01.019]
　SHEN Hangqi,HE Yannan.Effects of obesity on polycystic ovary syndrome from perspective of “obesity infertility”[J].,2024,(5):84.[doi:DOI:10.3969/j.issn.1000-7369.2024.01.019]
[12]高玖妹,高金金,梁锦铃,等.基于LncRNA探讨多囊卵巢综合征的发病机制与中医药干预研究进展[J].陕西中医,2025,46(1):134.[doi:DOI:10.3969/j.issn.1000-7369.2025.01.030]
　GAO Jiumei,GAO Jinjin,LIANG Jinling,et al.Research progress on pathogenesis of polycystic ovary syndrome and traditional Chinese medicine intervention based on LncRNA[J].,2025,46(5):134.[doi:DOI:10.3969/j.issn.1000-7369.2025.01.030]

备注/Memo

备注/Memo:
[基金项目]宁夏自治区重点研发计划项目(2022BEG03137); 第七批自治区青年科技人才托举工程项目[宁科协发组字(2023)6号]; 国家中医药管理局青年岐黄学者培养项目[国中医药人教函(2022)256号]; 中央财政转移支付地方项目(国家中医药管理局科技司)-中医药循证能力提升项目(妇科); 青年拔尖人才培养项目[宁人社函(2017)787号]
更新日期/Last Update: 2025-05-08